Carl Stubbings
Corporate Officer/Principal at GENETIC TECHNOLOGIES LIMITED
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Peter Irwin Rubinstein | M | - | 6 years | |
| J. Buchi | M | 69 |
Benitec Biopharma Ltd.
 Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 11 years |
| Geoff Cumming | M | - | 4 years | |
| Lindsay Wakefield | M | 65 | 10 years | |
| Jerzy Muchnicki | M | - | 6 years | |
| Peter Corr | M | 76 | 7 years | |
| Philip Powell | M | 65 | 4 years | |
| Peter Roelvink | M | - |
Benitec Biopharma Ltd.
Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 9 years |
| Simon Morriss | M | - | 3 years | |
| Erika Spaeth | M | - | 8 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Tony di Pietro | M | - | 2 years | |
| Helen Fisher | F | - | 2 years | |
| Mel Bridges | M | 73 |
Benitec Biopharma Ltd.
Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 7 years |
| John Chiplin | M | 66 | 2 years | |
| Irmgard Irminger-Finger | M | - | 5 years | |
| Nicholas Burrows | M | - | 5 years | |
| David J. Earp | M | 59 | 7 years | |
| Georgina H. Kilfoil | F | 55 |
Benitec Biopharma Ltd.
Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 4 years |
| Matthew Hoskin | M | - | 5 years | |
| Richard Allman | M | 63 | 18 years | |
| Thomas Lönngren | M | 73 | 5 years | |
| David Suhy | M | - |
Benitec Biopharma Ltd.
Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 6 years |
| Michael Graham | M | - |
Benitec Biopharma Ltd.
Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 3 years |
| Warren Stephen Brooks | M | - | 6 years | |
| Peter Gunzburg | M | 71 | - | |
| Peter Francis | M | 68 | - | |
| Stan Sack | M | - | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Australia | 27 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Carl Stubbings
- Personal Network
